These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 21958737
1. Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors. Tan CM, Chen GS, Chen CS, Chang PT, Chern JW. Bioorg Med Chem; 2011 Nov 01; 19(21):6316-28. PubMed ID: 21958737 [Abstract] [Full Text] [Related]
2. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production. Chen CS, Tan CM, Huang CH, Chang LC, Wang JP, Cheng FC, Chern JW. Bioorg Med Chem; 2010 Jan 15; 18(2):597-604. PubMed ID: 20056549 [Abstract] [Full Text] [Related]
3. Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents. Özadalı K, Özkanlı F, Jain S, Rao PP, Velázquez-Martínez CA. Bioorg Med Chem; 2012 May 01; 20(9):2912-22. PubMed ID: 22475926 [Abstract] [Full Text] [Related]
4. Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors. Lai Y, Ma L, Huang W, Yu X, Zhang Y, Ji H, Tian J. Bioorg Med Chem Lett; 2010 Dec 15; 20(24):7349-53. PubMed ID: 21055929 [Abstract] [Full Text] [Related]
5. Aspirin analogues as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, nitric oxide release, molecular modeling, and biological evaluation as anti-inflammatory agents. Kaur J, Bhardwaj A, Huang Z, Knaus EE. ChemMedChem; 2012 Jan 02; 7(1):144-50. PubMed ID: 22095955 [Abstract] [Full Text] [Related]
6. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs). Chen QH, Rao PN, Knaus EE. Bioorg Med Chem; 2006 Dec 01; 14(23):7898-909. PubMed ID: 16904331 [Abstract] [Full Text] [Related]
7. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases. Rao PN, Chen QH, Knaus EE. J Med Chem; 2006 Mar 09; 49(5):1668-83. PubMed ID: 16509583 [Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of indomethacin analogs possessing a N-difluoromethyl-1,2-dihydropyrid-2-one ring system: a search for novel cyclooxygenase and lipoxygenase inhibitors. Chowdhury MA, Huang Z, Abdellatif KR, Dong Y, Yu G, Velázquez CA, Knaus EE. Bioorg Med Chem Lett; 2010 Oct 01; 20(19):5776-80. PubMed ID: 20727750 [Abstract] [Full Text] [Related]
9. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Reddy MV, Billa VK, Pallela VR, Mallireddigari MR, Boominathan R, Gabriel JL, Reddy EP. Bioorg Med Chem; 2008 Apr 01; 16(7):3907-16. PubMed ID: 18272371 [Abstract] [Full Text] [Related]
10. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues. Zheng M, Zhang Z, Zhu W, Liu H, Luo X, Chen K, Jiang H. Bioorg Med Chem; 2006 May 15; 14(10):3428-37. PubMed ID: 16458008 [Abstract] [Full Text] [Related]
11. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase. Li Y, Chen SH, Ou TM, Tan JH, Li D, Gu LQ, Huang ZS. Bioorg Med Chem; 2011 Mar 15; 19(6):2074-83. PubMed ID: 21349729 [Abstract] [Full Text] [Related]
12. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes. Maghraby MT, Abou-Ghadir OMF, Abdel-Moty SG, Ali AY, Salem OIA. Bioorg Med Chem; 2020 Apr 01; 28(7):115403. PubMed ID: 32127262 [Abstract] [Full Text] [Related]
13. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity. Chowdhury MA, Abdellatif KR, Dong Y, Das D, Suresh MR, Knaus EE. Bioorg Med Chem Lett; 2008 Dec 01; 18(23):6138-41. PubMed ID: 18945614 [Abstract] [Full Text] [Related]
14. Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity. Jacob P J, Manju SL. Bioorg Chem; 2020 Jul 01; 100():103882. PubMed ID: 32361295 [Abstract] [Full Text] [Related]
15. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. Pontiki E, Hadjipavlou-Litina D, Litinas K, Nicolotti O, Carotti A. Eur J Med Chem; 2011 Jan 01; 46(1):191-200. PubMed ID: 21106277 [Abstract] [Full Text] [Related]
16. Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors. Suh J, Yum EK, Cheon HG, Cho YS. Chem Biol Drug Des; 2012 Jul 01; 80(1):89-98. PubMed ID: 22404847 [Abstract] [Full Text] [Related]
17. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase. Li L, Zeng H, Shan L, Yuan X, Li Y, Liu R, Zhang W. J Ethnopharmacol; 2012 Sep 28; 143(2):732-9. PubMed ID: 22884869 [Abstract] [Full Text] [Related]
18. Design, synthesis, and biological evaluation of (E)-3-(4-methanesulfonylphenyl)-2-(aryl)acrylic acids as dual inhibitors of cyclooxygenases and lipoxygenases. Moreau A, Chen QH, Praveen Rao PN, Knaus EE. Bioorg Med Chem; 2006 Dec 01; 14(23):7716-27. PubMed ID: 16931030 [Abstract] [Full Text] [Related]
19. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors. Cusan C, Spalluto G, Prato M, Adams M, Bodensieck A, Bauer R, Tubaro A, Bernardi P, Da Ros T. Farmaco; 2005 Apr 01; 60(4):327-32. PubMed ID: 15848208 [Abstract] [Full Text] [Related]
20. Discovery of potential anti-inflammatory drugs: diaryl-1,2,4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. Jiang B, Huang X, Yao H, Jiang J, Wu X, Jiang S, Wang Q, Lu T, Xu J. Org Biomol Chem; 2014 Apr 07; 12(13):2114-27. PubMed ID: 24562695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]